Several authors disclosed financial ties to the pharmaceutical industry. “It is important for health care professionals and the public to have information about early signs, symptoms and the time course of recovery of myocarditis, particularly as these vaccines become more widely available to children,” Truong said in a statement.
Suggestion For You:
Abstract/Full Text The researchers found that 136 patients (97.8 percent) had suspected myocarditis after mRNA vaccination; 131 (94.2 percent) occurred following the Pfizer-BioNTech vaccine and 128 (91.4 percent) were after the second dose. Symptom onset occurred at a median of two days after vaccination. Chest pain was the most common symptom (99.3 percent). Treatment included nonsteroidal anti-inflammatory drugs, intravenous immunoglobulin, glucocorticoids, colchicine, or no anti-inflammatory therapies (81.3, 21.6, 21.6, 7.9, and 8.6 percent, respectively). Overall, 26 patients (18.7 percent) were in the intensive care unit, two received inotropic/vasoactive support, and none required extracorporeal membrane oxygenation or died. The median hospital stay was two days. A total of 77.3 percent of the 97 patients who underwent cardiac magnetic resonance imaging at a median of five days from symptom onset had abnormal findings. All patients with left ventricular ejection fraction <55 percent on echocardiogram who received follow-up subsequently had normalized function.
The News Highlights
- COVID-19 Vaccine-Related Myocarditis in Young People Generally Mild – Consumer Health News
- Check the latest Health news updates and information about health.
For Latest News Follow us on Google News
- Show all
- Trending News
- Popular By week